Detection　of　minimal　residual　disease　in　leukemia　using　polymerase　chain　reaction　and　restriction　analysis

被引：0
|
作者：
吴南海
吕善根
朱平
刘乐宇
彭玉云
机构：
来源：
中华医学杂志(英文版) | 1997年 / 01期
关键词：
吕善根; leukemia; using; and; reaction; restriction; disease; residual; chain; polymerase; Detection; analysis;
D O I：
暂无
中图分类号：
R733.7 [白血病];
学科分类号：
100214 ;
摘要：
ＤｅｔｅｃｔｉｏｎｏｆｍｉｎｉｍａｌｒｅｓｉｄｕａｌｄｉｓｅａｓｅｉｎｌｅｕｋｅｍｉａｕｓｉｎｇｐｏｌｙｍｅｒａｓｅｃｈａｉｎｒｅａｃｔｉｏｎａｎｄｒｅｓｔｒｉｃｔｉｏｎａｎａｌｙｓｉｓＷｕＮａｎｈａｉ吴南海，ＬｕＳｈａｎｇｅｎ吕善根，ＺｈｕＰｉｎｇ...
引用
收藏
页码：71 / 75
页数：5
相关论文
共 50 条
  • [31] Assessment of residual disease in acute leukemia by means of polymerase chain reaction
    Ruiz-Argüelles, GJ
    Garcés-Eisele, J
    Reyes-Núñez, V
    Pérez-Romano, B
    Ruiz-Argüelles, A
    Ramírez-Cisneros, FJ
    López-Martínez, B
    López-Tapia, JD
    Rivadeneyra-Espinoza, L
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2000, 52 (02): : 118 - 124
  • [32] Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction
    Arons, E
    Margulies, I
    Sorbara, L
    Raffeld, M
    Stetler-Stevenson, M
    Pastan, I
    Kreitman, RJ
    CLINICAL CANCER RESEARCH, 2006, 12 (09) : 2804 - 2811
  • [33] THE USE OF THE POLYMERASE CHAIN-REACTION TO DETECT MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    STEWARD, CG
    GOULDEN, NJ
    POTTER, MN
    OAKHILL, A
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (08) : 1192 - 1198
  • [34] Detection of minimal residual disease in childhood B-lineage acute lymphoblastic leukemia using a quantitative semi-nested polymerase chain reaction.
    Gruhn, B
    Hafer, R
    Nyakatura, G
    Rosenthal, A
    Zintl, F
    BLOOD, 1995, 86 (10) : 1307 - 1307
  • [35] Minimal residual disease: the advantages of digital over analog polymerase chain reaction
    Ross, David M.
    Branford, Susan
    LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1161 - 1163
  • [36] Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?
    Faderl, S
    Talpaz, M
    Kantarjian, HM
    Estrov, Z
    BLOOD, 1999, 93 (09) : 2755 - 2759
  • [37] DETECTION OF MINIMAL RESIDUAL LEUKEMIA BY POLYMERASE CHAIN-REACTIONS - POTENTIAL IMPLICATIONS FOR THERAPY
    BARTRAM, CR
    JANSSEN, JWG
    HANSENHAGGE, TE
    FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY, 1992, 343 (01): : 20 - 20
  • [38] MINIMAL RESIDUAL DISEASE IN INTERFERON-TREATED CHRONIC MYELOGENOUS LEUKEMIA - RESULTS AND PITFALLS OF ANALYSIS BASED ON POLYMERASE CHAIN-REACTION
    DHINGRA, K
    KURZROCK, R
    KANTARJIAN, H
    BAINE, R
    EASTMAN, PS
    KU, S
    GUTTERMAN, JU
    TALPAZ, M
    LEUKEMIA, 1992, 6 (08) : 754 - 760
  • [39] DETECTION OF MINIMAL RESIDUAL DISEASE IN CHRONIC MYELOID-LEUKEMIA PATIENTS AFTER BONE-MARROW TRANSPLANTATION BY POLYMERASE CHAIN-REACTION
    DELFAU, MH
    KERCKAERT, JP
    DHOOGHE, MC
    FENAUX, P
    LAI, JL
    JOUET, JP
    GRANDCHAMP, B
    LEUKEMIA, 1990, 4 (01) : 1 - 5
  • [40] DETECTION OF MINIMAL RESIDUAL DISEASE BY POLYMERASE CHAIN-REACTION IN PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA FOLLOWING INTERFERON THERAPY
    LEE, MS
    KANTARJIAN, H
    TALPAZ, M
    FREIREICH, EJ
    DEISSEROTH, A
    TRUJILLO, JM
    STASS, SA
    BLOOD, 1992, 79 (08) : 1920 - 1923
12345